EJNMMI Research

Table 1 Clinical patient characteristics

From: Evaluation of [⁶⁸ Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria

Age (years)		Median 69, IQR 64—73
PSA at RP (ng/ml)		Median 8.1, IQR 5.6—12.6
pT-stage RP	T2	126 (42.4%)
	T3	170 (57.2%)
	T4	1 (0.3%)
ISUP grade	1	11 (3.7%)
	2	151 (50.8%)
	3	99 (33.3%)
	4	9 (3.0%)
	5	27 (9.1%)
Resection margin	R0	258 (86.9%)
Resection margin	R1	39 (13.1%)
pN-stage RP	N0	224 (75.4%)
	N1	50 (16.8%)
	No LN dissected	23 (7.7%)
RP to PET (months)		Median 37, IQR 15–75
PSA at PET/CT (ng/ml)	< 0.2	45 (15.2%)
	0.2–0.5	148 (49.8%)
	> 0.5–1.0	41 (13.8%)
	> 1.0	63 (21.2%)

IQR interquartile range; ISUP international society of urological pathology; LN lymph node; PSA prostate-specific antigen; and RP radical prostatectomy

Back to article page